Tregs in AD clinical trial A Phase II Clinical Trial of Interleukin-2 (IL-2) in Patients with Mild to Moderate Alzheimer?s Disease Progress

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date9/9/21 → …